Table 3.
Intervention strategies in 27 173 subjects with a Fatty Liver Index (FLI) < 60 and in 7067 subjects with a FLI ≥ 60 as function of total cardiovascular risk and low‐density lipoprotein cholesterol level
| Total CV risk (SCORE) | LDL cholesterol levels | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| <1.8 mmol/L | 1.8 to < 2.6 mmol/L | 2.6 to < 4.0 mmol/L | 4.0 to < 4.9 mmol/L | ≥4.9 mmol/L | ||||||
| FLI < 60 | FLI ≥ 60 | FLI < 60 | FLI ≥ 60 | FLI < 60 | FLI ≥ 60 | FLI < 60 | FLI ≥ 60 | FLI < 60 | FLI ≥ 60 | |
| <1%, or low risk | 870 (94.5) | 51 (5.5) | 5,600 (92.0) | 485 (8.0) | 11,242 (83.9) | 2,163 (16.1) | 1,836 (72.1) | 709 (27.9) | 334 (65.1) | 179 (34.9) |
| ≥1 to < 5%, or medium risk | 15 (71.4) | 6 (28.6) | 155 (72.8) | 58 (27.2) | 1,540 (71.6) | 612 (28.4) | 779 (66.9) | 385 (33.1) | 194 (59.1) | 134 (40.9) |
| ≥5 to < 10%, or high risk | 25 (71.4) | 10 (28.6) | 255 (78.2) | 71 (21.8) | 1,371 (66.6) | 688 (33.4) | 482 (54.5) | 403 (45.5) | 180 (57.5) | 133 (42.5) |
| ≥10%, or very high risk | 96 (87.3) | 14 (12.7) | 498 (83.8) | 96 (16.2) | 1,316 (70.3) | 556 (29.7) | 311 (56.1) | 243 (43.9) | 74 (51.0) | 71 (49.0) |
Table is based on Table 5 from the 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Data are given in numbers with percentages (%). Green cells represent no lipid intervention; yellow cells represent lifestyle intervention and if uncontrolled LDL cholesterol levels consideration of drug intervention; red cells represent drug intervention with concomitant lifestyle intervention. FLI = (e0.953*log(triglycerides) +0.139*BMI +0.718*log (GGT)+0.053*waist circumference‐15.745)/(1+e0.953*log(triglycerides)+0.139*BMI +0.718*log(GGT)+0.053*waist circumference‐15.745) × 100.